APO Research
Talk to an analyst

APO RESEARCH · REPORT

Nausea Medicine

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Nausea Medicine Market Outlook and Growth Opportunities 2026

20 December 2025196 pages

Choose your research edition.

Industry ResearchNausea Medicine Industry Research Report 2026116 pages · $2,950 USDIndustry Growth & TrendsGlobal Nausea Medicine Industry Growth and Trends Forecast to 203291 pages · $3,450 USDMarket StructureGlobal Nausea Medicine Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032183 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Nausea Medicine Market Outlook and Growth Opportunities 2026196 pages · $4,250 USDMarket Analysis & ForecastGlobal Nausea Medicine Market Analysis and Forecast 2026-2032191 pages · $4,950 USD

Market perspective

The global Nausea Medicine market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Nausea Medicine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Nausea Medicine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Nausea Medicine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Nausea Medicine market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Nausea Medicine market include Sanofi, Merck, Roche, Pfizer, GlaxoSmithKline, TESARO and ANI Pharmaceuticals, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Nausea Medicine market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Nausea Medicine and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Nausea Medicine sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Nausea Medicine market size, projected growth trends, production technologies, key applications, and end-use industries.

Nausea Medicine Segment by Company

Sanofi

Merck

Roche

Pfizer

GlaxoSmithKline

TESARO

ANI Pharmaceuticals

Nausea Medicine Segment by Type

Antagonists

Antacids

Steroids

Others

Nausea Medicine Segment by Application

Pharmaceutical Companies

Clinics

Hospital

Nausea Medicine Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Nordic Countries

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global Nausea Medicine status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Nausea Medicine market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Nausea Medicine significant trends, drivers, influence factors in global and regions.

6. To analyze Nausea Medicine competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Nausea Medicine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Nausea Medicine and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Nausea Medicine.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Nausea Medicine market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Nausea Medicine industry.

Chapter 3: Detailed analysis of Nausea Medicine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Nausea Medicine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Nausea Medicine in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Nausea Medicine Industry Trends Table 2. Nausea Medicine Industry Drivers Table 3. Nausea Medicine Industry Opportunities and Challenges Table 4. Nausea Medicine Industry Restraints Table 5. Global Nausea Medicine Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Nausea Medicine Revenue Share by Company (2021-2026) Table 7. Global Nausea Medicine Sales Volume by Company (K Units) & (2021-2026) Table 8. Global Nausea Medicine Sales Volume Share by Company (2021-2026) Table 9. Global Nausea Medicine Average Price (US$/Unit) of Company (2021-2026) Table 10. Global Nausea Medicine Company Ranking, (2024-2026) & (USD Million) Table 11. Global Nausea Medicine Key Company Manufacturing Base & Headquarters Table 12. Global Nausea Medicine Company, Product Type & Application Table 13. Global Nausea Medicine Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Nausea Medicine by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Antagonists Table 18. Significant Companies of Antacids Table 19. Significant Companies of Steroids Table 20. Significant Companies of Others Table 21. Global Nausea Medicine Sales Volume by Type 2021 VS 2025 VS 2032 (K Units) Table 22. Global Nausea Medicine Sales Volume by Type (2021-2026) & (K Units) Table 23. Global Nausea Medicine Sales Volume by Type (2027-2032) & (K Units) Table 24. Global Nausea Medicine Sales Volume Share by Type (2021-2026) Table 25. Global Nausea Medicine Sales Volume Share by Type (2027-2032) Table 26. Global Nausea Medicine Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 27. Global Nausea Medicine Sales Value by Type (2021-2026) & (US$ Million) Table 28. Global Nausea Medicine Sales Value by Type (2027-2032) & (US$ Million) Table 29. Global Nausea Medicine Sales Value Share by Type (2021-2026) Table 30. Global Nausea Medicine Sales Value Share by Type (2027-2032) Table 31. Significant Companies of Pharmaceutical Companies Table 32. Significant Companies of Clinics Table 33. Significant Companies of Hospital Table 34. Global Nausea Medicine Sales Volume by Application 2021 VS 2025 VS 2032 (K Units) Table 35. Global Nausea Medicine Sales Volume by Application (2021-2026) & (K Units) Table 36. Global Nausea Medicine Sales Volume by Application (2027-2032) & (K Units) Table 37. Global Nausea Medicine Sales Volume Share by Application (2021-2026) Table 38. Global Nausea Medicine Sales Volume Share by Application (2027-2032) Table 39. Global Nausea Medicine Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 40. Global Nausea Medicine Sales Value by Application (2021-2026) & (US$ Million) Table 41. Global Nausea Medicine Sales Value by Application (2027-2032) & (US$ Million) Table 42. Global Nausea Medicine Sales Value Share by Application (2021-2026) Table 43. Global Nausea Medicine Sales Value Share by Application (2027-2032) Table 44. Global Nausea Medicine Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 45. Global Nausea Medicine Sales by Region (2021-2026) & (K Units) Table 46. Global Nausea Medicine Sales Market Share by Region (2021-2026) Table 47. Global Nausea Medicine Sales by Region (2027-2032) & (K Units) Table 48. Global Nausea Medicine Sales Market Share by Region (2027-2032) Table 49. Global Nausea Medicine Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 50. Global Nausea Medicine Sales Value by Region (2021-2026) & (US$ Million) Table 51. Global Nausea Medicine Sales Value Share by Region (2021-2026) Table 52. Global Nausea Medicine Sales Value by Region (2027-2032) & (US$ Million) Table 53. Global Nausea Medicine Sales Value Share by Region (2027-2032) Table 54. Global Nausea Medicine Market Average Price (US$/Unit) by Region (2021-2026) Table 55. Global Nausea Medicine Market Average Price (US$/Unit) by Region (2027-2032) Table 56. Global Nausea Medicine Sales by Country: 2021 VS 2025 VS 2032 (K Units) Table 57. Global Nausea Medicine Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 58. Global Nausea Medicine Sales by Country (2021-2026) & (K Units) Table 59. Global Nausea Medicine Sales Market Share by Country (2021-2026) Table 60. Global Nausea Medicine Sales by Country (2027-2032) & (K Units) Table 61. Global Nausea Medicine Sales Market Share by Country (2027-2032) Table 62. Global Nausea Medicine Sales Value by Country (2021-2026) & (US$ Million) Table 63. Global Nausea Medicine Sales Value Market Share by Country (2021-2026) Table 64. Global Nausea Medicine Sales Value by Country (2027-2032) & (US$ Million) Table 65. Global Nausea Medicine Sales Value Market Share by Country (2027-2032) Table 66. Sanofi Company Information Table 67. Sanofi Business Overview Table 68. Sanofi Nausea Medicine Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 69. Sanofi Nausea Medicine Product Portfolio Table 70. Sanofi Recent Development Table 71. Merck Company Information Table 72. Merck Business Overview Table 73. Merck Nausea Medicine Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 74. Merck Nausea Medicine Product Portfolio Table 75. Merck Recent Development Table 76. Roche Company Information Table 77. Roche Business Overview Table 78. Roche Nausea Medicine Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 79. Roche Nausea Medicine Product Portfolio Table 80. Roche Recent Development Table 81. Pfizer Company Information Table 82. Pfizer Business Overview Table 83. Pfizer Nausea Medicine Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 84. Pfizer Nausea Medicine Product Portfolio Table 85. Pfizer Recent Development Table 86. GlaxoSmithKline Company Information Table 87. GlaxoSmithKline Business Overview Table 88. GlaxoSmithKline Nausea Medicine Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 89. GlaxoSmithKline Nausea Medicine Product Portfolio Table 90. GlaxoSmithKline Recent Development Table 91. TESARO Company Information Table 92. TESARO Business Overview Table 93. TESARO Nausea Medicine Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 94. TESARO Nausea Medicine Product Portfolio Table 95. TESARO Recent Development Table 96. ANI Pharmaceuticals Company Information Table 97. ANI Pharmaceuticals Business Overview Table 98. ANI Pharmaceuticals Nausea Medicine Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 99. ANI Pharmaceuticals Nausea Medicine Product Portfolio Table 100. ANI Pharmaceuticals Recent Development Table 101. Key Raw Materials Table 102. Raw Materials Key Suppliers Table 103. Nausea Medicine Distributors List Table 104. Nausea Medicine Customers List Table 105. Research Programs/Design for This Report Table 106. Authors List of This Report Table 107. Secondary Sources Table 108. Primary Sources List of Figures Figure 1. Nausea Medicine Product Image Figure 2. Global Nausea Medicine Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Nausea Medicine Sales Value (2021-2032) & (US$ Million) Figure 4. Global Nausea Medicine Sales (2021-2032) & (K Units) Figure 5. Global Nausea Medicine Sales Average Price (US$/Unit) & (2021-2032) Figure 6. Global Nausea Medicine Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Antagonists Image Figure 10. Antacids Image Figure 11. Steroids Image Figure 12. Others Image Figure 13. Global Nausea Medicine Sales Volume by Type (2021 VS 2025 VS 2032) & (K Units) Figure 14. Global Nausea Medicine Sales Volume Share 2021 VS 2025 VS 2032 Figure 15. Global Nausea Medicine Sales Volume Share by Type (2021-2032) Figure 16. Global Nausea Medicine Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 17. Global Nausea Medicine Sales Value Share 2021 VS 2025 VS 2032 Figure 18. Global Nausea Medicine Sales Value Share by Type (2021-2032) Figure 19. Pharmaceutical Companies Image Figure 20. Clinics Image Figure 21. Hospital Image Figure 22. Global Nausea Medicine Sales Volume by Application (2021 VS 2025 VS 2032) & (K Units) Figure 23. Global Nausea Medicine Sales Volume Share 2021 VS 2025 VS 2032 Figure 24. Global Nausea Medicine Sales Volume Share by Application (2021-2032) Figure 25. Global Nausea Medicine Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 26. Global Nausea Medicine Sales Value Share 2021 VS 2025 VS 2032 Figure 27. Global Nausea Medicine Sales Value Share by Application (2021-2032) Figure 28. Global Nausea Medicine Sales by Region: 2021 VS 2025 VS 2032 (K Units) Figure 29. Global Nausea Medicine Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 30. Global Nausea Medicine Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 31. Global Nausea Medicine Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 32. North America Nausea Medicine Sales Value (2021-2032) & (US$ Million) Figure 33. North America Nausea Medicine Sales Value Share by Country (%), 2025 VS 2032 Figure 34. Europe Nausea Medicine Sales Value (2021-2032) & (US$ Million) Figure 35. Europe Nausea Medicine Sales Value Share by Country (%), 2025 VS 2032 Figure 36. Asia-Pacific Nausea Medicine Sales Value (2021-2032) & (US$ Million) Figure 37. Asia-Pacific Nausea Medicine Sales Value Share by Country (%), 2025 VS 2032 Figure 38. South America Nausea Medicine Sales Value (2021-2032) & (US$ Million) Figure 39. South America Nausea Medicine Sales Value Share by Country (%), 2025 VS 2032 Figure 40. Middle East & Africa Nausea Medicine Sales Value (2021-2032) & (US$ Million) Figure 41. Middle East & Africa Nausea Medicine Sales Value Share by Country (%), 2025 VS 2032 Figure 42. USA Nausea Medicine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 43. USA Nausea Medicine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 44. USA Nausea Medicine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 45. Canada Nausea Medicine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 46. Canada Nausea Medicine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 47. Canada Nausea Medicine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 48. Mexico Nausea Medicine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 49. Mexico Nausea Medicine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 50. Mexico Nausea Medicine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 51. Germany Nausea Medicine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 52. Germany Nausea Medicine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 53. Germany Nausea Medicine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 54. France Nausea Medicine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 55. France Nausea Medicine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 56. France Nausea Medicine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 57. U.K. Nausea Medicine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 58. U.K. Nausea Medicine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 59. U.K. Nausea Medicine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 60. Italy Nausea Medicine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 61. Italy Nausea Medicine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 62. Italy Nausea Medicine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 63. Spain Nausea Medicine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 64. Spain Nausea Medicine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 65. Spain Nausea Medicine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 66. Russia Nausea Medicine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 67. Russia Nausea Medicine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 68. Russia Nausea Medicine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 69. Netherlands Nausea Medicine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 70. Netherlands Nausea Medicine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 71. Netherlands Nausea Medicine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 72. Nordic Countries Nausea Medicine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 73. Nordic Countries Nausea Medicine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 74. Nordic Countries Nausea Medicine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 75. China Nausea Medicine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 76. China Nausea Medicine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 77. China Nausea Medicine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 78. Japan Nausea Medicine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 79. Japan Nausea Medicine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 80. Japan Nausea Medicine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 81. South Korea Nausea Medicine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 82. South Korea Nausea Medicine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 83. South Korea Nausea Medicine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 84. India Nausea Medicine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 85. India Nausea Medicine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 86. India Nausea Medicine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 87. Australia Nausea Medicine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 88. Australia Nausea Medicine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 89. Australia Nausea Medicine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 90. Southeast Asia Nausea Medicine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 91. Southeast Asia Nausea Medicine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 92. Southeast Asia Nausea Medicine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 93. Brazil Nausea Medicine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 94. Brazil Nausea Medicine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 95. Brazil Nausea Medicine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 96. Argentina Nausea Medicine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 97. Argentina Nausea Medicine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 98. Argentina Nausea Medicine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 99. Chile Nausea Medicine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 100. Chile Nausea Medicine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 101. Chile Nausea Medicine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 102. Colombia Nausea Medicine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 103. Colombia Nausea Medicine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 104. Colombia Nausea Medicine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 105. Peru Nausea Medicine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 106. Peru Nausea Medicine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 107. Peru Nausea Medicine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 108. Saudi Arabia Nausea Medicine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 109. Saudi Arabia Nausea Medicine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 110. Saudi Arabia Nausea Medicine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 111. Israel Nausea Medicine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 112. Israel Arabia Nausea Medicine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 113. Israel Arabia Nausea Medicine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 114. UAE Nausea Medicine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 115. UAE Nausea Medicine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 116. UAE Nausea Medicine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 117. Turkey Nausea Medicine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 118. Turkey Nausea Medicine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 119. Turkey Nausea Medicine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 120. Iran Nausea Medicine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 121. Iran Nausea Medicine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 122. Iran Nausea Medicine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 123. Egypt Nausea Medicine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 124. Egypt Nausea Medicine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 125. Egypt Nausea Medicine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 126. Nausea Medicine Value Chain Figure 127. Manufacturing Cost Structure Figure 128. Nausea Medicine Sales Mode & Process Figure 129. Direct Comparison with Distribution Share Figure 130. Distributors Profiles Figure 131. Years Considered Figure 132. Research Process Figure 133. Key Executives Interviewed

Scope & coverage.

Types
  • Antagonists
  • Antacids
  • Steroids
  • Others
Applications
  • Pharmaceutical Companies
  • Clinics
  • Hospital
Companies covered
  • Sanofi
  • Merck
  • Roche
  • Pfizer
  • GlaxoSmithKline
  • TESARO
  • ANI Pharmaceuticals

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Nausea Medicine Sales Value (2021-2032)
  4. 1.2.2 Global Nausea Medicine Sales Volume (2021-2032)
  5. 1.2.3 Global Nausea Medicine Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Nausea Medicine Market Dynamics
  1. 2.1 Nausea Medicine Industry Trends
  2. 2.2 Nausea Medicine Industry Drivers
  3. 2.3 Nausea Medicine Industry Opportunities and Challenges
  4. 2.4 Nausea Medicine Industry Restraints
3 Nausea Medicine Market by Company
  1. 3.1 Global Nausea Medicine Company Revenue Ranking in 2025
  2. 3.2 Global Nausea Medicine Revenue by Company (2021-2026)
  3. 3.3 Global Nausea Medicine Sales Volume by Company (2021-2026)
  4. 3.4 Global Nausea Medicine Average Price by Company (2021-2026)
  5. 3.5 Global Nausea Medicine Company Ranking (2024-2026)
  6. 3.6 Global Nausea Medicine Company Manufacturing Base and Headquarters
  7. 3.7 Global Nausea Medicine Company Product Type and Application
  8. 3.8 Global Nausea Medicine Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Nausea Medicine Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Nausea Medicine Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Nausea Medicine Market by Type
  1. 4.1 Nausea Medicine Type Introduction
  2. 4.1.1 Antagonists
  3. 4.1.2 Antacids
  4. 4.1.3 Steroids
  5. 4.1.4 Others
  6. 4.2 Global Nausea Medicine Sales Volume by Type
  7. 4.2.1 Global Nausea Medicine Sales Volume by Type (2021 VS 2025 VS 2032)
  8. 4.2.2 Global Nausea Medicine Sales Volume by Type (2021-2032)
  9. 4.2.3 Global Nausea Medicine Sales Volume Share by Type (2021-2032)
  10. 4.3 Global Nausea Medicine Sales Value by Type
  11. 4.3.1 Global Nausea Medicine Sales Value by Type (2021 VS 2025 VS 2032)
  12. 4.3.2 Global Nausea Medicine Sales Value by Type (2021-2032)
  13. 4.3.3 Global Nausea Medicine Sales Value Share by Type (2021-2032)
5 Nausea Medicine Market by Application
  1. 5.1 Nausea Medicine Application Introduction
  2. 5.1.1 Pharmaceutical Companies
  3. 5.1.2 Clinics
  4. 5.1.3 Hospital
  5. 5.2 Global Nausea Medicine Sales Volume by Application
  6. 5.2.1 Global Nausea Medicine Sales Volume by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Nausea Medicine Sales Volume by Application (2021-2032)
  8. 5.2.3 Global Nausea Medicine Sales Volume Share by Application (2021-2032)
  9. 5.3 Global Nausea Medicine Sales Value by Application
  10. 5.3.1 Global Nausea Medicine Sales Value by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Nausea Medicine Sales Value by Application (2021-2032)
  12. 5.3.3 Global Nausea Medicine Sales Value Share by Application (2021-2032)
6 Nausea Medicine Regional Sales and Value Analysis
  1. 6.1 Global Nausea Medicine Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Nausea Medicine Sales by Region (2021-2032)
  3. 6.2.1 Global Nausea Medicine Sales by Region: 2021-2026
  4. 6.2.2 Global Nausea Medicine Sales by Region (2027-2032)
  5. 6.3 Global Nausea Medicine Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Nausea Medicine Sales Value by Region (2021-2032)
  7. 6.4.1 Global Nausea Medicine Sales Value by Region: 2021-2026
  8. 6.4.2 Global Nausea Medicine Sales Value by Region (2027-2032)
  9. 6.5 Global Nausea Medicine Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Nausea Medicine Sales Value (2021-2032)
  12. 6.6.2 North America Nausea Medicine Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Nausea Medicine Sales Value (2021-2032)
  15. 6.7.2 Europe Nausea Medicine Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Nausea Medicine Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Nausea Medicine Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Nausea Medicine Sales Value (2021-2032)
  21. 6.9.2 South America Nausea Medicine Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Nausea Medicine Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Nausea Medicine Sales Value Share by Country, 2025 VS 2032
7 Nausea Medicine Country-level Sales and Value Analysis
  1. 7.1 Global Nausea Medicine Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Nausea Medicine Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Nausea Medicine Sales by Country (2021-2032)
  4. 7.3.1 Global Nausea Medicine Sales by Country (2021-2026)
  5. 7.3.2 Global Nausea Medicine Sales by Country (2027-2032)
  6. 7.4 Global Nausea Medicine Sales Value by Country (2021-2032)
  7. 7.4.1 Global Nausea Medicine Sales Value by Country (2021-2026)
  8. 7.4.2 Global Nausea Medicine Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Nausea Medicine Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Nausea Medicine Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Nausea Medicine Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Nausea Medicine Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Nausea Medicine Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Nausea Medicine Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Nausea Medicine Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Nausea Medicine Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Nausea Medicine Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Nausea Medicine Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Nausea Medicine Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Nausea Medicine Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Nausea Medicine Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Nausea Medicine Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Nausea Medicine Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Nausea Medicine Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Nausea Medicine Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Nausea Medicine Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Nausea Medicine Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Nausea Medicine Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Nausea Medicine Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Nausea Medicine Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Nausea Medicine Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Nausea Medicine Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Nausea Medicine Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Nausea Medicine Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Nausea Medicine Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Nausea Medicine Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Nausea Medicine Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Nausea Medicine Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Nausea Medicine Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Nausea Medicine Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Nausea Medicine Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Nausea Medicine Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Nausea Medicine Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Nausea Medicine Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Nausea Medicine Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Nausea Medicine Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Nausea Medicine Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Nausea Medicine Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Nausea Medicine Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Nausea Medicine Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Nausea Medicine Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Nausea Medicine Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Nausea Medicine Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Nausea Medicine Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Nausea Medicine Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Nausea Medicine Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Nausea Medicine Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Nausea Medicine Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Nausea Medicine Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Nausea Medicine Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Nausea Medicine Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Nausea Medicine Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Nausea Medicine Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Nausea Medicine Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Nausea Medicine Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Nausea Medicine Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Nausea Medicine Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Nausea Medicine Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Nausea Medicine Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Nausea Medicine Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Nausea Medicine Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Nausea Medicine Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Nausea Medicine Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Nausea Medicine Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Nausea Medicine Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Nausea Medicine Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Nausea Medicine Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Nausea Medicine Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Nausea Medicine Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Nausea Medicine Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Nausea Medicine Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Nausea Medicine Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Nausea Medicine Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Nausea Medicine Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Nausea Medicine Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Nausea Medicine Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Nausea Medicine Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Nausea Medicine Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Nausea Medicine Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Nausea Medicine Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Nausea Medicine Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Nausea Medicine Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Sanofi
  2. 8.1.1 Sanofi Company Information
  3. 8.1.2 Sanofi Business Overview
  4. 8.1.3 Sanofi Nausea Medicine Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Sanofi Nausea Medicine Product Portfolio
  6. 8.1.5 Sanofi Recent Developments
  7. 8.2 Merck
  8. 8.2.1 Merck Company Information
  9. 8.2.2 Merck Business Overview
  10. 8.2.3 Merck Nausea Medicine Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Merck Nausea Medicine Product Portfolio
  12. 8.2.5 Merck Recent Developments
  13. 8.3 Roche
  14. 8.3.1 Roche Company Information
  15. 8.3.2 Roche Business Overview
  16. 8.3.3 Roche Nausea Medicine Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Roche Nausea Medicine Product Portfolio
  18. 8.3.5 Roche Recent Developments
  19. 8.4 Pfizer
  20. 8.4.1 Pfizer Company Information
  21. 8.4.2 Pfizer Business Overview
  22. 8.4.3 Pfizer Nausea Medicine Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Pfizer Nausea Medicine Product Portfolio
  24. 8.4.5 Pfizer Recent Developments
  25. 8.5 GlaxoSmithKline
  26. 8.5.1 GlaxoSmithKline Company Information
  27. 8.5.2 GlaxoSmithKline Business Overview
  28. 8.5.3 GlaxoSmithKline Nausea Medicine Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 GlaxoSmithKline Nausea Medicine Product Portfolio
  30. 8.5.5 GlaxoSmithKline Recent Developments
  31. 8.6 TESARO
  32. 8.6.1 TESARO Company Information
  33. 8.6.2 TESARO Business Overview
  34. 8.6.3 TESARO Nausea Medicine Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 TESARO Nausea Medicine Product Portfolio
  36. 8.6.5 TESARO Recent Developments
  37. 8.7 ANI Pharmaceuticals
  38. 8.7.1 ANI Pharmaceuticals Company Information
  39. 8.7.2 ANI Pharmaceuticals Business Overview
  40. 8.7.3 ANI Pharmaceuticals Nausea Medicine Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 ANI Pharmaceuticals Nausea Medicine Product Portfolio
  42. 8.7.5 ANI Pharmaceuticals Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Nausea Medicine Value Chain Analysis
  2. 9.1.1 Nausea Medicine Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Nausea Medicine Sales Mode & Process
  6. 9.2 Nausea Medicine Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Nausea Medicine Distributors
  9. 9.2.3 Nausea Medicine Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst